LTP001, Placebo to LTP001 1mg and 5mg hard gelatin capsules, LTP001
CADPT09A12201
Phase 2 small_molecule active
Quick answer
LTP001, Placebo to LTP001 1mg and 5mg hard gelatin capsules, LTP001 for Idiopathic pulmonary fibrosis is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Idiopathic pulmonary fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active